After several days of worry that the global AIDS program might come to abrupt end, Secretary of State Marco Rubio issued a ...

Robert F. Kennedy Jr., the HHS secretary nominee, has said he is not antivaccine, but he has a track record of casting doubt ...

At today's confirmation hearing, Democratic senators were skeptical of the HHS Secretary nominee Robert F. Kennedy Jr.'s ...

Chronic kidney disease affects about 37 million adults in the United States and is expected to rise. It is a common ...

The survey also showed that high drug costs and artificial intelligence are topmost among the respondent’s concerns.

Panelists discuss the potential role of emerging treatments in the progressive pulmonary fibrosis (PPF) landscape if approved ...

As the nation is again under the reigns of a Trump administration and a Republican-led Congress, debates on reducing spending ...

Panelists discuss the key gaps and unmet needs in current management strategies for progressive pulmonary fibrosis (PPF) and ...

A panelist discusses how she proactively addresses safety concerns about neurokinin-targeted therapies through evidence-based ...

The drug received accelerated approval in October 2017 as monotherapy for adults with MCL who have received at least one ...

A monthly 10 mg/mL maintenance dose of Leqembi had the same effects on mild Alzheimer’s symptoms as biweekly dose, research ...

As with PTSD, people develop acute stress disorder after exposure to traumatic events. The key difference in the diagnostic ...